New injection for high blood pressure enters first human tests
NCT ID NCT06823947
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This early-stage trial is testing a new drug called KK3910 in healthy people and those with high blood pressure. The main goal is to check safety and how the drug moves through the body. It is a small, placebo-controlled study, so it is too soon to know if the drug actually works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KK3910
What this could lead to
If successful, this could lead to a new injectable treatment option for high blood pressure.
What could go wrong
This is a very early Phase 1 trial focused on safety, not effectiveness. It is small and may not show enough benefit or may have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kitasato University Kitasato Institute Hospital
RECRUITINGMinato-ku, Tokyo, 108-8642, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical Corporation Heishinkai OPHAC Hospital
NOT_YET_RECRUITINGYodogawa, Osaka, 532-0003, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SOUSEIKAI PS Clinic
NOT_YET_RECRUITINGHakata, Fukuoka, 812-0025, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••